0000950170-24-066826.txt : 20240530
0000950170-24-066826.hdr.sgml : 20240530
20240530180914
ACCESSION NUMBER: 0000950170-24-066826
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kowieski Mark
CENTRAL INDEX KEY: 0002024869
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 241006987
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 420 STEVENS AVENUE, SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
3
1
ownership.xml
3
X0206
3
2024-05-22
0
0001403708
Evoke Pharma Inc
EVOK
0002024869
Kowieski Mark
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 230
SOLANA BEACH
CA
92075
false
true
false
false
Chief Financial Officer
Common Stock
5000
I
By IRA
Stock Option (Right to Buy)
2.09
2032-06-12
Common Stock
16000
D
Stock Option (Right to Buy)
4.01
2033-02-07
Common Stock
7500
D
The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of June 13, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.
The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2023, subject to the reporting person's continuous service to the issuer on each such vesting date.
/s/ Mark Kowieski
2024-05-30